Knowledge Hub

Healthcare, Regulatory and Reimbursement Landscape Market Forcast To Grow At CAGR Of 9.5% Between 2016-2020

Press Release   •   Oct 24, 2016 04:55 EDT

Healthcare, Regulatory and Reimbursement Landscape Malaysia. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Malaysia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and inhouse analysis by GlobalDatas team of industry experts.

In 2013, Malaysias population stood at 29.9 million. The past five years have seen steady population growth, which is expected to continue in the future due to a high birth rate, low mortality rate and increased life expectancy. Government initiatives such as Entry Point Projects (EPPs), specifically EPP3, and National Key Economic Areas (NKEAs) to increase investment in the pharmaceutical industry have so far have been successful. The countrys pharmaceutical market was estimated at $1.2 billion in 2008 and is projected to reach approximately $3.7 billion by 2020 at a CAGR of 9.5%. The medical device market was worth approximately $585m in 2010, but is growing and currently constitutes approximately 25% of the healthcare expenditure.

  • These positive trends can primarily be attributed to
  • An increasing elderly population
  • Government initiatives to improve healthcare facilities
  • An increase in medical tourism

Download Sample copy of this Report at :


  • The report provides information on the healthcare, regulatory, and reimbursement landscape in Malaysia, and includes
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Chemical Company of Malaysia Berhad, Pharmaniaga Berhad, Hovid Berhad, Apex Healthcare Berhad and Y.S.P. Southeast Asia Holding Berhad
  • Insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Malaysian healthcare market

Reasons to buy

  • This report will enhance your decisionmaking capability by allowing you to
  • Develop business strategies by understanding the trends shaping and driving Malaysias healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in Malaysias healthcare market

Follow us on LinkedIn:

Table of Contents

1 Table of Contents 6

1.1 List of Tables 9

1.2 List of Figures 12

2 Introduction 16

2.1 GlobalData Report Guidance 16

3 Overview of Pharmaceutical and Medical Device Markets 17

3.1 Pharmaceutical Market 17

3.1.1 Market Overview 17

3.1.2 Pharmaceutical Exports and Imports 22

3.1.3 Supply Channels 24

3.1.4 Market Segments 25

3.1.5 Overview of Top Five Disease Areas 28

3.1.6 Major Players 32

3.2 Medical Device Market 60

3.2.1 Market Overview 60

3.3 Market Drivers and Barriers 62

3.3.1 Drivers 62

3.3.2 Barriers 63

4 Market Access 65

4.1 Reimbursement and Payer Landscape 65

4.1.1 Overview of Healthcare System 65

4.1.2 Reimbursement Process 66

4.1.3 Overview of Insurance Providers 69

4.1.4 Patient Share in Healthcare Spending 72

4.1.5 Price Trend in Healthcare Services 73

4.1.6 Pricing Policies 74

4.2 Regulatory Landscape 74

4.2.1 Overview of Regulatory Agencies 74

4.2.2 Market Authorization Procedure for Pharmaceutical Products 75

4.2.3 Market Authorization Procedure for Medical Devices 80

4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 83

4.2.5 Licensing Process for Pharmaceutical Exports and Imports 85

4.2.6 Intellectual Property Rights 86

4.2.7 Clinical Trial Regulations 90

4.2.8 Pharmaceutical Advertising Regulations 93

4.2.9 Pharmacy Regulations 95

4.2.10 Labeling and Packaging Regulations 96 is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.